Associations of myosteatosis with disc degeneration: A 3T magnetic resonance imaging study in individuals with impaired glycaemia.
body composition
diabetes
imaging biomarker
intervertebral disc degeneration
magnetic resonance imaging
myosteatosis
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
revised:
11
11
2022
received:
01
04
2022
accepted:
22
01
2023
medline:
5
6
2023
pubmed:
10
3
2023
entrez:
9
3
2023
Statut:
ppublish
Résumé
Intervertebral disc degeneration (IVDD) may be linked to dysregulations of skeletal muscle glucose metabolism and fatty alterations of muscle composition (Myosteatosis). Our aim was to evaluate the different associations of magnetic resonance imaging (MRI)-based paravertebral myosteatosis with lumbar disc degeneration in individuals with impaired glucose metabolism and normoglycaemic controls. In total, 304 individuals (mean age: 56.3 ± 9.1 years, 53.6% male sex, mean body mass index [BMI]: 27.6 ± 4.7 kg/m The overall prevalence of IVDD was 79.6%. There was no significant difference in the prevalence or severity distribution of IVDD between participants with or without impaired glucose metabolism (77.7% vs. 80.7%, P = 0.63 and P = 0.71, respectively). PDFF Paravertebral myosteatosis is positively associated with intervertebral disc disease in individuals with impaired glucose metabolism, independent of age, sex and BMI. Regular physical activity may confound these associations. Longitudinal studies will help to better understand the pathophysiological role of skeletal muscle in those with concomitant disturbed glucose haemostasis and intervertebral disc disease, as well as possible underlying causal relationships.
Sections du résumé
BACKGROUND
Intervertebral disc degeneration (IVDD) may be linked to dysregulations of skeletal muscle glucose metabolism and fatty alterations of muscle composition (Myosteatosis). Our aim was to evaluate the different associations of magnetic resonance imaging (MRI)-based paravertebral myosteatosis with lumbar disc degeneration in individuals with impaired glucose metabolism and normoglycaemic controls.
METHODS
In total, 304 individuals (mean age: 56.3 ± 9.1 years, 53.6% male sex, mean body mass index [BMI]: 27.6 ± 4.7 kg/m
RESULTS
The overall prevalence of IVDD was 79.6%. There was no significant difference in the prevalence or severity distribution of IVDD between participants with or without impaired glucose metabolism (77.7% vs. 80.7%, P = 0.63 and P = 0.71, respectively). PDFF
CONCLUSIONS
Paravertebral myosteatosis is positively associated with intervertebral disc disease in individuals with impaired glucose metabolism, independent of age, sex and BMI. Regular physical activity may confound these associations. Longitudinal studies will help to better understand the pathophysiological role of skeletal muscle in those with concomitant disturbed glucose haemostasis and intervertebral disc disease, as well as possible underlying causal relationships.
Identifiants
pubmed: 36892104
doi: 10.1002/jcsm.13192
pmc: PMC10235864
doi:
Substances chimiques
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1249-1258Informations de copyright
© 2023 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
Références
Acta Radiol. 2022 Jun;63(6):750-759
pubmed: 33878932
Ageing Res Rev. 2021 Sep;70:101398
pubmed: 34214642
Eur Spine J. 2021 Apr;30(4):837-845
pubmed: 32594231
Clin Geriatr Med. 2015 Feb;31(1):67-87, viii
pubmed: 25453302
Eur Radiol. 2021 Oct;31(10):7566-7574
pubmed: 33768291
Diabetes Metab Res Rev. 2018 Oct;34(7):e3042
pubmed: 29931823
Am J Sports Med. 2012 Aug;40(8):1728-34
pubmed: 22753846
PLoS One. 2021 Jun 9;16(6):e0252385
pubmed: 34106962
Br J Radiol. 2018 Sep;91(1089):20180019
pubmed: 29658780
Radiol Oncol. 2020 Mar 27;54(2):237-246
pubmed: 32229679
Neurosurgery. 2017 Mar 01;80(3S):S46-S54
pubmed: 28350945
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2259-2261
pubmed: 34904399
World Neurosurg. 2019 Feb;122:e1069-e1077
pubmed: 30415054
J Appl Physiol (1985). 2021 Jan 1;130(1):245-255
pubmed: 33180646
Eur J Radiol. 2018 Aug;105:261-268
pubmed: 30017292
Joint Bone Spine. 2019 Nov;86(6):725-730
pubmed: 30584921
Muscle Nerve. 2014 Aug;50(2):170-6
pubmed: 24677256
Rheumatol Int. 2019 Apr;39(4):627-635
pubmed: 30852623
Eur Spine J. 2021 Dec;30(12):3428-3441
pubmed: 34542672
Skeletal Radiol. 2018 Jul;47(7):955-961
pubmed: 29379999
Curr Opin Clin Nutr Metab Care. 2010 May;13(3):260-4
pubmed: 20179586
Asian Spine J. 2009 Jun;3(1):39-44
pubmed: 20404946
J Cachexia Sarcopenia Muscle. 2023 Jun;14(3):1249-1258
pubmed: 36892104
Spine (Phila Pa 1976). 2001 Sep 1;26(17):1873-8
pubmed: 11568697
Asian Spine J. 2016 Apr;10(2):377-84
pubmed: 27114783
Orthop Surg. 2014 Feb;6(1):23-7
pubmed: 24590989
PLoS One. 2015 Feb 10;10(2):e0116625
pubmed: 25668621
J Orthop Surg Res. 2018 Mar 14;13(1):52
pubmed: 29540205
Curr Opin Rheumatol. 2017 Mar;29(2):214-222
pubmed: 28072592
Diabetes. 2017 Jan;66(1):158-169
pubmed: 27999110
Front Physiol. 2020 Aug 07;11:963
pubmed: 32903666
Sci Rep. 2020 Jul 16;10(1):11765
pubmed: 32678260
Diabetes Obes Metab. 2021 Aug;23(8):1868-1878
pubmed: 33914415
BMC Musculoskelet Disord. 2018 Jul 28;19(1):271
pubmed: 30055599
Bone Res. 2021 Jan 29;9(1):7
pubmed: 33514693
Global Spine J. 2020 Aug;10(5):657-666
pubmed: 32677568
Eur Radiol. 2019 Feb;29(2):599-608
pubmed: 30014202
Ann N Y Acad Sci. 2015 Sep;1353:41-59
pubmed: 26250623
BMC Musculoskelet Disord. 2016 Oct 21;17(1):439
pubmed: 27765024
Prog Rehabil Med. 2020 Jul 15;5:20200015
pubmed: 32844128
Eur Geriatr Med. 2019 Feb;10(1):5-6
pubmed: 32720282